Rivaroxaban RIVAROX

Synonyms

Allscripts (AEHR) Order Name

Rivaroxaban (Xarelto)

Sunrise Clinical Manager (SCM) Order Name

Rivaroxaban (Xarelto) Level

Clinical Info

Rivaroxaban is an oral factor Xa inhibitor that is indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. It is also indicated for the treatment, prophylaxis, or the reduction in the risk of reoccurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE). Rivaroxaban does not need to be monitored routinely, however, exceptions may include determination of failure of therapy vs. poor compliance, or potential dose adjustment required for renal or hepatic dysfunction.

Specimen Type

Blood

Container

Blue Top Tube

Collection Instructions

Container/Tube: 3.2 % Light blue Top (sodium citrate) tube
Specimen: 1 mL plasma (0.5 ml min)
transport Temperature: Frozen
 
Patient Preparation:  Collect samples 2 - 4 hours post dose (peak)
 
Set Up Monday, Wednesday and Friday
TAT: 2 - 3 Days

Transport Instructions

Frozen

Specimen Stability

Methodology

Chromogenic

Days Performed

Performing Laboratory

Quest Diagnostics' Nichols Institute, Inc. - Chantilly

CPT

80299
 
LOINC Code - 72624-0

PDM

1759180

Result Interpretation

*The lower limit of detection for this assay is 30 mcg/L. The ranges are based on literature references

Forms